Drug Type Small molecule drug |
Synonyms ML163 |
Target |
Mechanism α-synuclein agonists(Synuclein?alpha agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diagnostic agents | Preclinical | US | 04 Feb 2011 |